CDXS codexis.com: Bozor kapitallashuvining balans qiymatiga nisbati

codexis.com (CDXS) - korporativ logo

GURU.Markets platformasidagi Codexis, Inc. (CDXS) aktivlari narxi grafigi zararli emissiyalarni kamaytirish uchun barqaror fermentlar ishlab chiqishga ESG tamoyillarini joriy qilayotgan kompaniyaning dinamikasini aks ettiradi. Joriy ko'rsatkich 3.62 hisoblanadi. Biznes protein muhandisligi platformasiga tayanadi, nisha risklarini minimallashtirish uchun oziq-ovqat sanoati va tibbiyot sohalaridagi ishtirokini kengaytirmoqda. Masshtablash modeli biokatalizator litsenziyalarini sotishga asoslangan bo'lib, bu ishlab chiqarish xarajatlarisiz royalti oqimini ta'minlaydi.

codexis.com (CDXS): Kapitallashuvning balans qiymatiga nisbati 04.07.2022dan 27.10.2026gacha

Codexis, Inc. (CDXS) moliyaviy va bozor koʻrsatkichlari kesimi

- narx va narxlar bo'yicha konsensus prognoz:
Narx grafigi codexis.com|CDXS - Tahlilchilar median maqsadi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi Codexis Bio|CDXS - Biznes qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar Codexis, Inc.|CDXS - Buxgalteriya kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati codexis.com|CDXS - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Codexis, Inc.|CDXS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati codexis.com|CDXS - Kompaniyaning umumiy yig'indi qarzi|Balans kapitallashuviga qarzlar Codexis Bio
Kompaniyaning dastlabki tahlili:CDXS, Codexis Inc
codexis.com tayyor mahsulotlari

Ushbu koeffitsiyent sof kapitaldan yuqori bo'lgan bozor narxi premiumini belgilaydi va joriy aktivlarga nisbatan kelajakdagi pul oqimlariga investorlarning ishonch darajasini aks ettiradi. Hozirgi qiymati 3.62 bo'lgan ushbu bozor qiymatining buxgalteriya qiymatiga nisbati (market-to-book multiple) grafigini tahlil qilish orqali, bozor CodeEvolver platformasining intellektual salohiyatini va Codexis, Inc. kompaniyasining biosintez sohasidagi tadqiqot va ishlanmalar (R&D) xarajatlarini qanchalik darajada kapitallashtirayotganini baholash mumkin.

Raqobatchilar tahlili

Tempus Labs - Bozor qiymatining balans qiymatiga nisbati|qiagen.com (QGEN) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati Ionis (IONS)|Kapitallashuvning balans qiymatiga nisbati RGEN|Bozor qiymatining balans qiymatiga nisbati Avidity RNA|Kapitallashuvning balans qiymatiga nisbati CRISPR (CRSP)|Bozor kapitallashuvining balans qiymatiga nisbati WGS (GeneDx Holdings Corp.)|Bozor kapitallashuvining balans qiymatiga nisbati ultragenyx.com RARE|BEAM: Bozor kapitallashuvining balans qiymatiga nisbati|SRPT: Kapitallashuvning sof aktivlarga nisbati|Bozor qiymatining balans qiymatiga nisbati TWST|10x (TXG) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor kapitallashuvining balans qiymatiga nisbati Intellia Therapeutics (NTLA)|Kapitallashuvning balans qiymatiga nisbati stoketherapeutics.com|BioLife Solutions - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Wave Life Sciences Ltd WVE|MAZE - Kapitallashuvning sof aktivlarga nisbati|Kapitallashuvning balans qiymatiga nisbati Sionna Corp SION|Bozor kapitallashuvining balans qiymatiga nisbati PRME (Prime Medicine, Inc.)|TSHA: Balans qiymatiga nisbatan bozor kapitallashuvi|uniQure - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi MeiraGTx Holdings|RGNX - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Solid Corp|OCGN (Ocugen, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi PACB (pacb.com)|BNTC - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati Design Therapeutics Inc DSGN|RCKT: Bozor kapitallashuvining balans qiymatiga nisbati|4D Molecular Corp (FDMT) - Kapitallashuvning sof aktivlarga nisbati|lexeotx.com - Kapitallashuvning sof aktivlarga nisbati|Korro Bio (KRRO) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati EDIT|Kapitallashuvning sof aktivlarga nisbati Silence Therapeutics PLC|Bozor kapitallashuvining balans qiymatiga nisbati ProQR Therapeutics N.V. PRQR|Kapitallashuvning balans qiymatiga nisbati Sangamo BioSciences SGMO|NAUT - Kapitallashuvning sof aktivlarga nisbati|metagenomi.co - Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati DTIL (Precision BioSciences)|GBIO - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati Boundless Bio, Inc|XCUR (Exicure) - Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Imunon Inc (IMNN)|Kapitallashuvning balans qiymatiga nisbati RXi Pharmaceuticals|Bozor kapitallashuvining balans qiymatiga nisbati MBIO|Bozor kapitallashuvining balans qiymatiga nisbati transcodetherapeutics.com (RNAZ)|Bionano Genomics - Bozor kapitallashuvining balans qiymatiga nisbati|Applied DNA Corp - Kapitallashuvning sof aktivlarga nisbati|BLUE (bluebird bio, Inc.) - Bozor qiymatining balans qiymatiga nisbati|IPA - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor kapitallashuvining balans qiymatiga nisbati Omega Therapeutics, Inc.|Singular Genomics Systems, Inc. (OMIC) - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati RGLS (Regulus Therapeutics Inc)|Bozor qiymatining balans qiymatiga koeffitsiyenti Syros Pharmaceuticals, Inc (SYRS)|Kapitallashuvning sof aktivlarga nisbati Telesis Bio, Inc. TBIO|Kapitallashuvning balans qiymatiga nisbati traconpharma.com (TCON)|Bozor kapitallashuvining balans qiymatiga nisbati UBX